Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Paediatric Toxic Shock Syndrome
NCT02219165Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2015
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in toxic shock syndrome (TSS), sponsored by Hospices Civils de Lyon. Started Jan 2015; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
toxic shock syndrome (TSS)
Beyond the preview
Go deeper on NCT02219165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219165.